Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07) Sara A. Hurvitz , Jennifer L. Caswell-Jin , Katherine McNamara , Jason J. Zoeller , Gregory R. Bean , Robert Dichmann , Alejandra Perez , Ravindranath Patel , Lee M. Zehngebot , Heather Allen , Linda D. Bosserman , Brian DiCarlo , April L. Kennedy , Armando E. Giuliano , Carmen Calfa , David Molthrop , Aruna Mani , Hsiao-Wang Chen , Judy Dering , Brad Adams , Eran Kotler , Michael F. Press , Joan S. Brugge , Christina Curtis , Dennis J. Slamon medRxiv (Cold Spring Harbor Laboratory)（2020）
关键词
neoadjuvant trastuzumab, breast cancer, lapatinib
AI 理解论文
溯源树
样例
